Atherosclerosis of native coronary artery of transplanted heart without angina pectoris
ICD-10 I25.811 is a billable code used to indicate a diagnosis of atherosclerosis of native coronary artery of transplanted heart without angina pectoris.
I25.811 refers to atherosclerosis of the native coronary artery of a transplanted heart without angina pectoris. This condition arises when there is a buildup of plaque within the coronary arteries that supply blood to the heart muscle of a transplanted organ. The clinical presentation may vary, but it often includes asymptomatic phases, as patients may not exhibit angina pectoris. The anatomy involved includes the coronary arteries that originate from the aorta and supply blood to the heart muscle. Disease progression can lead to significant ischemic heart disease, heart failure, or even myocardial infarction if not monitored and managed appropriately. Diagnostic considerations include imaging studies such as coronary angiography, which can reveal the extent of atherosclerotic changes. Regular follow-up and monitoring are crucial in post-transplant patients to detect any signs of graft dysfunction or coronary artery disease early on.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
I25.811 specifically covers atherosclerosis affecting the native coronary arteries of a transplanted heart, without the presence of angina pectoris. This includes cases where the patient may experience other symptoms or be asymptomatic.
I25.811 should be used when a patient has a documented diagnosis of atherosclerosis in the native coronary arteries of a transplanted heart without any episodes of angina. If angina is present, I25.810 would be more appropriate.
Documentation should include a detailed history of the patient's heart transplant, any symptoms experienced, results from diagnostic imaging, and a clear treatment plan that reflects the management of atherosclerosis.
